Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
21.07 USD | -5.00% | -6.36% | +17.38% |
Financials (USD)
Sales 2024 * | 134M | Sales 2025 * | 218M | Capitalization | 1.03B |
---|---|---|---|---|---|
Net income 2024 * | -211M | Net income 2025 * | -134M | EV / Sales 2024 * | 6.56 x |
Net cash position 2024 * | 151M | Net cash position 2025 * | 175M | EV / Sales 2025 * | 3.93 x |
P/E ratio 2024 * |
-5.11
x | P/E ratio 2025 * |
-8.87
x | Employees | 344 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 91.87% |
Latest transcript on REGENXBIO Inc.
1 day | -5.00% | ||
1 week | -6.36% | ||
Current month | +20.81% | ||
1 month | +5.88% | ||
3 months | +13.65% | ||
6 months | +19.17% | ||
Current year | +17.38% |
Managers | Title | Age | Since |
---|---|---|---|
Kenneth Mills
FOU | Founder | 49 | 08-07-15 |
Vit Vasista
DFI | Director of Finance/CFO | 56 | 09-07-31 |
Chief Tech/Sci/R&D Officer | - | 15-10-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
George Migausky
BRD | Director/Board Member | 69 | 21-09-02 |
David Stump
BRD | Director/Board Member | 74 | 15-10-14 |
Director/Board Member | 71 | 15-04-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.76% | 17 M€ | -0.46% | ||
0.25% | 26 M€ | +0.78% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 21.07 | -5.00% | 487,057 |
24-03-27 | 22.18 | +2.35% | 561,385 |
24-03-26 | 21.67 | +0.37% | 345,696 |
24-03-25 | 21.59 | -0.87% | 302,600 |
24-03-22 | 21.78 | -3.20% | 279,146 |
Delayed Quote Nasdaq, March 28, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+17.38% | 1.03B | |
+2.73% | 108B | |
+9.59% | 103B | |
+6.58% | 23.48B | |
-12.59% | 21.93B | |
-3.29% | 19.68B | |
-35.36% | 18.37B | |
-13.29% | 16.33B | |
+4.68% | 13.72B | |
+34.25% | 12.15B |